197 related articles for article (PubMed ID: 31185171)
21. CD71
Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
Mol Cancer Res; 2019 Sep; 17(9):1867-1880. PubMed ID: 31235657
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma.
Chan KT; Choi MY; Lai KK; Tan W; Tung LN; Lam HY; Tong DK; Lee NP; Law S
Oncol Rep; 2014 Mar; 31(3):1296-304. PubMed ID: 24435655
[TBL] [Abstract][Full Text] [Related]
23. CD71 antibody enhances iron uptake by mouse bone marrow cells and the survival potential of erythroid progenitor cells.
Honda KI; Ishiko O; Hato F; Kitagawa S; Jikihara I; Yoshida H; Ogita S
Int J Mol Med; 2001 Aug; 8(2):135-40. PubMed ID: 11445863
[TBL] [Abstract][Full Text] [Related]
24. Protease sensitivity and redistribution of CD71 and glycophorin A on K562 cells.
Yu CH; Wang H; Wang Y; Cui NX; Zhao X; Rong L; Yi ZC
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):40-45. PubMed ID: 28980921
[TBL] [Abstract][Full Text] [Related]
25. Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia.
Smilevska T; Stamatopoulos K; Samara M; Belessi C; Tsompanakou A; Paterakis G; Stavroyianni N; Athanasiadou I; Chiotoglou I; Hadzidimitriou A; Athanasiadou A; Douka V; Saloum R; Laoutaris N; Anagnostopoulos A; Fassas A; Stathakis N; Kollia P
Leuk Res; 2006 Feb; 30(2):183-9. PubMed ID: 16054692
[TBL] [Abstract][Full Text] [Related]
26. Cryo-EM structure of the human ferritin-transferrin receptor 1 complex.
Montemiglio LC; Testi C; Ceci P; Falvo E; Pitea M; Savino C; Arcovito A; Peruzzi G; Baiocco P; Mancia F; Boffi A; des Georges A; Vallone B
Nat Commun; 2019 Mar; 10(1):1121. PubMed ID: 30850661
[TBL] [Abstract][Full Text] [Related]
27. Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal Adenocarcinoma.
Champanhac C; Teng IT; Cansiz S; Zhang L; Wu X; Zhoa Z; Fu T; Tan W
Sci Rep; 2015 Nov; 5():16788. PubMed ID: 26603187
[TBL] [Abstract][Full Text] [Related]
28. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
[TBL] [Abstract][Full Text] [Related]
29. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
30. Selection and targeting of EpCAM protein by ssDNA aptamer.
Alshaer W; Ababneh N; Hatmal M; Izmirli H; Choukeife M; Shraim A; Sharar N; Abu-Shiekah A; Odeh F; Al Bawab A; Awidi A; Ismail S
PLoS One; 2017; 12(12):e0189558. PubMed ID: 29245156
[TBL] [Abstract][Full Text] [Related]
31. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of proliferation and differentiation during early T cell development by anti-transferrin receptor antibody.
Brekelmans P; van Soest P; Leenen PJ; van Ewijk W
Eur J Immunol; 1994 Nov; 24(11):2896-902. PubMed ID: 7957580
[TBL] [Abstract][Full Text] [Related]
33. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
[TBL] [Abstract][Full Text] [Related]
34. Blind SELEX Approach Identifies RNA Aptamers That Regulate EMT and Inhibit Metastasis.
Yoon S; Armstrong B; Habib N; Rossi JJ
Mol Cancer Res; 2017 Jul; 15(7):811-820. PubMed ID: 28396463
[TBL] [Abstract][Full Text] [Related]
35. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
[TBL] [Abstract][Full Text] [Related]
36. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric measurement of NK cell cytotoxicity.
Hoshino T; Hara A; Inoue M; Honda J; Imai Y; Oizumi K; Yokoyama MM
J Clin Lab Immunol; 1991 Sep; 36(1):39-43. PubMed ID: 1668860
[TBL] [Abstract][Full Text] [Related]
38. Lateral membrane protein associations of CD4 in lymphoid cells detected by cross-linking and mass spectrometry.
Bernhard OK; Sheil MM; Cunningham AL
Biochemistry; 2004 Jan; 43(1):256-64. PubMed ID: 14705953
[TBL] [Abstract][Full Text] [Related]
39. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
40. Cancer cell targeting using multiple aptamers conjugated on nanorods.
Huang YF; Chang HT; Tan W
Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
